# Intercept Pharmaceuticals

**Type:** Funders  
**Canonical URL:** https://scholariq.org/funders/intercept-pharmaceuticals/

## Facts

| Field | Value |
| --- | --- |
| Country | US |
| Description | American biopharmaceutical company |
| OpenAlex ID | https://openalex.org/F4320318040 |
| ROR ID | https://ror.org/01sx6jc36 |
| Works | 444 |

## Funder papers

- [Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial](https://scholariq.org/papers/long-term-kidney-outcomes-of-semaglutide-in-obesity-and-cardiovascular-disease/)
- [Impact of Oral Semaglutide on Kidney Outcomes in People With Type 2 Diabetes: Results From the SOUL Randomized Trial](https://scholariq.org/papers/impact-of-oral-semaglutide-on-kidney-outcomes-in-people-with-type-2-diabetes/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.